scholarly article | Q13442814 |
P2093 | author name string | Tao Zhang | |
David C Gale | |||
Jingjing Ye | |||
Chunze Li | |||
Ellen Y Wu | |||
Sue Zhou | |||
Eric Y Zhang | |||
Cathie D Xiang | |||
Minerva Batugo | |||
P433 | issue | 5 | |
P304 | page(s) | 992-998 | |
P577 | publication date | 2009-02-12 | |
P1433 | published in | Drug Metabolism and Disposition | Q1261140 |
P1476 | title | Characterization of human corneal epithelial cell model as a surrogate for corneal permeability assessment: metabolism and transport | |
P478 | volume | 37 |
Q98895679 | Amantadine can induce intra-epithelial deposition in the cornea |
Q39171184 | Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines |
Q54219035 | Characterization of monocarboxylate uptake and immunohistochemical demonstration of monocarboxylate transporters in cultured rabbit corneal epithelial cells. |
Q39492528 | Cytotoxicity assays of new artificial tears containing 2-methacryloyloxyethyl phosphorylcholine polymer for ocular surface cells |
Q53527063 | Design and development of an in vitro tear replenishment system. |
Q35170366 | Development of a curved, stratified, in vitro model to assess ocular biocompatibility |
Q28542904 | Extended latanoprost release from commercial contact lenses: in vitro studies using corneal models |
Q45073331 | Fast Dissolving Dendrimer Nanofiber Mats as Alternative to Eye Drops for More Efficient Antiglaucoma Drug Delivery. |
Q38695101 | In vitro and ex vivo corneal penetration and absorption models. |
Q37850457 | In vitro cell culture models to study the corneal drug absorption |
Q40500118 | Interaction Studies of Resolvin E1 Analog (RX-10045) with Efflux Transporters |
Q39760193 | Interaction of ocular hypotensive agents (PGF2 alpha analogs-bimatoprost, latanoprost, and travoprost) with MDR efflux pumps on the rabbit cornea |
Q37682926 | Multifunctional organic-inorganic hybrid nanoparticles and nanosheets based on chitosan derivative and layered double hydroxide: cellular uptake mechanism and application for topical ocular drug delivery |
Q51122641 | Ocular Drug Delivery. |
Q30475605 | Ocular drug delivery |
Q35187905 | Ocular pharmacokinetics of dorzolamide and brinzolamide after single and multiple topical dosing: implications for effects on ocular blood flow |
Q39273066 | Pigmented-MDCK (P-MDCK) cell line with tunable melanin expression: an in vitro model for the outer blood-retinal barrier |
Q41891370 | Potential pharmacokinetic role of organic cation transporters in modulating the transcorneal penetration of its substrates administered topically |
Q42031044 | Probenecid treatment enhances retinal and brain delivery of N-4-benzoylaminophenylsulfonylglycine: an anionic aldose reductase inhibitor |
Q35950189 | Prodrug approach to improve absorption of prednisolone |
Q38913947 | Upregulation of P-glycoprotein expression by ophthalmic drugs in different corneal in-vitro models |
Q35990861 | mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs |
Search more.